Skip to main content
. 2018 Feb 20;11(2):374–390. doi: 10.1016/j.tranon.2018.01.006

Figure 3.

Figure 3

Frequency of researches about NHERF1 divided for cancer. The majority of the studies explore the role of NHERF1 in breast and colorectal cancer, followed by tumors of the central nervous system, urogenital tract and pancreas. 15% includes studies about: hepatocarcinoma, melanoma, esophageal, biliary, gastric and lung cancer.